Effects of acute angiotensin II type 1 receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic parameters in patients with heart failure.
D E
DE
Vaughan
N J
NJ
Brown
D000804:Angiotensin II / Q000378:metabolism*; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D002940:Circadian Rhythm; D004347:Drug Interactions; D004656:Enalapril / Q000627:therapeutic use; D005342:Fibrinolysis / Q000187:drug effects*; D006333:Heart Failure / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D019808:Losartan / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D044140:Receptor, Angiotensin, Type 1; D044139:Receptor, Angiotensin, Type 2; D012084:Renin-Angiotensin System / Q000187:drug effects
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D044140:Receptor, Angiotensin, Type 1; D044139:Receptor, Angiotensin, Type 2; D000804:Angiotensin II; D004656:Enalapril; D019808:Losartan